SOLICITATION NOTICE
A -- Combined Activity to Abstract Data from Persons Receiving Ambulatory Care for HIV Infection in the United States
- Notice Date
- 5/5/2006
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2006-N-08536
- Response Due
- 5/19/2006
- Archive Date
- 6/3/2006
- Description
- NOTICE OF INTENT TO SOLE SOURCE: The Centers for Disease Control and Prevention (CDC) announces its intention to negotiate a sole source follow-on contract with Cerner Corporation to augment research, data collection and other related activities among a cohort of HIV ?infected persons receiving care at 15 HIV ?specialty ambulatory clinics in several United States cities. The anticipated performance period is five years. The contractor will be required to continue to collect and assure the quality of data collected from HIV care sites?notably, the patients? demographics, social and behavioral characteristics, physical signs and symptoms, medical diagnoses, treatments, laboratory values, and will propose and execute at least two sub-studies within the framework of such data collection. The sub-studies shall include clinical, epidemiologic, laboratory, and social-behavioral issues in HIV infection. Specifically, the Contractor shall perform the following tasks in this project: TASK 1: Data Abstraction and Entry from 15 study-sites treating HIV ?infected adult patients (at least 75 patients per study site per year). The Contractor shall collect and assure the quality of data collected from the HIV study sites within the data management system. These activities shall include database entry of patient visit information within the study sites? protocol and patient consent. TASK 2: The data shall be entered into the Clinical Practice Analyst (CPA), and the contractor shall provide technical support for the CPA and modify the software as requested by CDC. TASK 3: Provide and assure the completeness and accuracy of data by data-management training for on-site personnel to each study site and site visit to assure the timely, complete and accurate addition of data to the overall database; and ongoing quality assurance-driven data management. TASK 4: The Contractor shall ensure all study sites maintain their local IRB approvals with annual renewals. All approvals and final clearances (CDC and local IRB?s, FWA?s and other applicable requirements) must be obtained for the protocol acquired under TASK 1 above. TASK 5: Conduct and execute at least two sub-studies relevant to the prevention and treatment of HIV infection within the cohort of enrolled patients to address issues that emerge during the course of the study and as a result of the evolving knowledge about HIV/AIDS. These issues may include mortality and morbidity of HIV infection in the era of highly active antiretroviral therapy (HAART), treatment and prevention of opportunistic illnesses, and the treatment and prevention of complications related to the use of HAART and attendant longer survival. The sub-studies shall include clinical, epidemiologic, laboratory and social-behavioral issues in HIV infection TASK 6: Organize and execute a two-day annual meeting for this project. Participants will include CDC staff, Contractor?s staff, investigators, and others from study sites. TASK 7: The Contactor shall provide statistical support for at least eight new and separate scientific analyses of the data. Analyses will be conducted in consultation with and under the guidance of CDC. All presentations and publications from data analyses under the contract will be restricted. Cerner Corporation?s long-term experience with this study will help ensure the most efficient implementation of this project for the following reasons: a) Cerner Corporation has worked on this project for 13 years and is already intimately familiar with the study sites, agency?s requirements, and past and ongoing information on the ?existing? cohort of patients. b) Cerner Corporation?s past participation and continued partnerships are critical for resolving ongoing resolutions and/or remediation. c) Time constraints imposed by CDC for target patients? group data, publications, site monitoring and reporting, require Cerner Corporation?s continued work on this project. Cerner Corporation?s experience and history with the project will ensure timely reporting and meeting CDC?s requirements. It is critical to the study to continue to collect longitudinal, ongoing information on the ?existing? cohort of patients from the original source than to any other source which would result in unacceptable delays in fulfilling CDC?s requirement. Hence, a follow-on contract with Cerner Corporation would be the most efficient and cost effective way to deliver services that are critical and essential to meet CDC?s requirement. CDC intends to negotiate this requirement with Cerner Corporation under the authority of FAR 6.302-1, HHSAR 306.302-1, and 10 U.S.C. 2304(c) (1). Any other responsible sources may submit a statement of qualifications and experience which, if timely received, will be evaluated by CDC to determine if a competitive solicitation should be issued. Responses must be received on May 16, 2006, at 4 PM, Eastern Standard Time (EST). Collect calls will not be accepted. Responses may be E-mailed to Betty Vannoy at bbv9@cdc.gov. Questions concerning this proposed acquisition may be directed to Betty Vannoy, Contract Specialist. See Notes 22 and 26. Point of Contact Betty Vannoy, Contact Specialist, Telephone No. 404-639-8293, Fax No. 404-639-8059, E-mail address: bbv9@cdc.gov
- Place of Performance
- Address: Kansas City, MO
- Zip Code: 64117
- Country: USA
- Zip Code: 64117
- Record
- SN01042636-W 20060507/060505221533 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |